Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2-anilino nicotinic acid | 16344-26-6 | MFCD03114306 | 99.9% | 248.67 g·mol⁻¹ | C12H9ClN2O2 | 5 MG
SDP

Catalog No. 5000264868
Encompass_Preferred

DHODH-IN-17 is a 2-anilino nicotinic acid small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH) with a reported IC50 of 0.40 μM. It is intended for use in in vitro and preclinical research applications, including studies related to acute myeloid leukemia.

  • High purity: 99.9%.
  • Molecular formula C12H9ClN2O2.
  • Molecular weight 248.67 g·mol⁻¹.
  • Reported DHODH IC50 0.40 μM.
  • Available in small mg pack sizes suitable for early-stage studies.
  • Certificate of analysis provided for lot-specific data.
  • Suitable for in vitro and preclinical research workflows.

Catalog No. 50-002-64868 Supplier Medchemexpress LLC Supplier No. HY1280685MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DHODH-IN-17 is a 2-anilino nicotinic acid small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH) with a reported IC50 of 0.40 μM. It is intended for use in in vitro and preclinical research applications, including studies related to acute myeloid leukemia.

  • High purity: 99.9%.
  • Molecular formula C12H9ClN2O2.
  • Molecular weight 248.67 g·mol⁻¹.
  • Reported DHODH IC50 0.40 μM.
  • Available in small mg pack sizes suitable for early-stage studies.
  • Certificate of analysis provided for lot-specific data.
  • Suitable for in vitro and preclinical research workflows.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.